In a recent report, experts have cautioned that the risk profiling of embryos for genetic anomalies is not yet deemed suitable for widespread use. The technology, which involves screening embryos for potential genetic abnormalities before implantation, is still in its early stages and requires more research and validation. While it holds promise for individuals with genetic disorders, concerns have been raised about the accuracy and reliability of the testing. As of now, experts suggest that caution should be exercised in utilizing this technology until further advancements and improvements are made.
Source link
Polygenic Risk Scores: New Frontier in IVF or Just a Hype?
